|
Age-related macular degeneration (ARMD)
|
CFH, CFHR3, CFHR1, CFHR2, 1q23
|
P236-ARMD mix-1basic research
|
€ 1145€ 572.50
|
|
Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
|
GNAS 20q13.32
|
ME031-GNASbasic research
|
€ 1145€ 572.50
|
|
Atherosclerotic cardiovascular disease (risk of)
|
9q21.3
|
P273-PCSK5newbasic research
|
€ 1145
|
|
Chemokines
|
CXCR4, CX3CR1, CCR5, CCR2, CD4, CD209
|
P247-Chemokine-2basic research
|
€ 1145€ 572.50
|
|
Cytochrome P-450
|
CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1
|
P128-CYP450basic research
|
€ 1145€ 572.50
|
|
DPP6, CRKL
|
DPP6, CRKL
|
P349-DPP6-CRKLbasic research
|
€ 1145€ 572.50
|
|
FCGR genes 1q23.3
|
FCGR genes 1q23.3
|
P111-FCGR mix 2basic research
|
€ 1145€ 801.50
|
|
FCGR genes 1q23.3
|
FCGR genes 1q23.3
|
P110-FCGR mix 1basic research
|
€ 1145€ 801.50
|
|
Neurodegenerative diseases
|
NOS1 12q24
|
P299-NOSbasic research
|
€ 1145€ 572.50
|
|
Repair genes
|
Various
|
ME046-Repairbasic research
|
€ 1145€ 572.50
|
|
Rh blood group antigens
|
RHD 1p36.2-1p34
|
P119-RHDbasic research
|
€ 1145€ 572.50
|
|
Tumour analysis
|
RBM14, 11q13
|
P284-RBM14-11q13basic research
|
€ 1145€ 572.50
|
|
Tumour suppressor genes
|
Various
|
ME002-Tumor sup.-2basic research
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME001-Tumor sup.-1basic research
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME003-Tumor sup.-3basic research
|
€ 1145
|
|
Tumour suppressor genes
|
Various
|
ME004-Tumor sup.-4basic research
|
€ 1145
|
|
Tumour-Loss
|
various
|
P294-Tumour-Lossbasic research
|
€ 1145€ 687
|
|
Tumour-gain
|
various
|
P175-Tumour-Gainbasic research
|
€ 1145€ 687
|